MARKET

INNMF

INNMF

Amplia Therapeutics Ltd
OTCMQB
0.100
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.100
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.240
52 WEEK LOW
0.029
MARKET CAP
51.31M
P/E (TTM)
-7.4074
1D
5D
1M
3M
1Y
5Y
1D
AMPLIA THERAPEUTICS LTD: KEY NARMAFOTINIB PATENT GRANTED IN U.S.
Reuters · 3d ago
Amplia Therapeutics Granted Key U.S. Patent for Narmafotinib, Extending Protection to 2040
Reuters · 3d ago
Key Narmafotinib Patent Granted in the U.S.
Barchart · 3d ago
Amplia Therapeutics Reports Promising Trial Results for Pancreatic Cancer Drug
TipRanks · 11/27 07:27
Amplia Therapeutics Receives FDA Support for Pancreatic Cancer Trial
TipRanks · 11/20 01:08
Amplia Therapeutics Issues New Equity Securities
TipRanks · 11/10 05:57
Amplia Therapeutics Expands U.S. Market Presence with OTCQB Listing
TipRanks · 10/30 22:57
Amplia Therapeutics Advances Narmafotinib Trials with Promising Results
TipRanks · 10/28 23:27
More
About INNMF
Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.

Webull offers Amplia Therapeutics Ltd stock information, including OTCMQB: INNMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INNMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INNMF stock methods without spending real money on the virtual paper trading platform.